Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.
Flora Growth Corp (FLGC) operates at the intersection of cannabis cultivation and pharmaceutical distribution, maintaining a vertically integrated model across 15+ countries. This page delivers essential updates about corporate milestones, regulatory compliance, and market expansion efforts.
Investors and industry observers will find comprehensive coverage of earnings reports, strategic partnerships, product launches, and operational developments. Our aggregation ensures you stay informed about FLGC’s commercial wholesale activities, consumer brand portfolio, and pharmaceutical-grade medical solutions.
Key updates include international supply chain advancements, CBD product innovations, and compliance achievements in regulated markets. Bookmark this page for real-time access to Flora Growth’s press releases and third-party analysis, curated to support informed decision-making.
Flora Growth Corp. (NASDAQ: FLGC) has completed its specialized beverage facility, marking its entry into the $220 million beverage market. The facility incorporates Peak's proven technology, ensuring high-quality products and a competitive edge. With over 100 formulations, Flora aims to power major cannabis brands, replicating Peak's success in Canada, where it produces nearly 40% of cannabis beverages.
The THC-infused beverage market is rapidly growing, representing 2.1% of the Canadian adult-use cannabis market (CAD$134.4 million). In the U.S., beverages account for 1% to 3% of the cannabis market, with significant growth potential. Data Bridge Market Research projects the U.S. infused beverages market to reach half a billion by 2030, growing at a CAGR of 14.7%.
Flora's facility will produce beverages for its Melo brand and others, enabling strategic distribution agreements. The company's joint venture with Peak, formed in June 2024, combines Peak's production expertise with Flora's brand launching and marketing capabilities in the U.S.
Flora Growth Corp. (NASDAQ: FLGC) expresses optimism following Vice President Kamala Harris' campaign proposal to legalize recreational marijuana at the federal level. Harris aims to work with Congress to make cultivation, distribution, and possession of recreational cannabis legal across the United States. Currently, recreational marijuana is legal in 24 states and D.C., but remains illegal federally.
Former President Donald Trump has also voiced support for cannabis legalization, pledging to vote for a Florida measure legalizing recreational marijuana. Flora's CEO, Clifford Starke, sees this bi-partisan momentum towards federal cannabis legalization as historic. The company believes legalization would provide clarity for businesses and open doors for communities impacted by outdated cannabis laws.
Flora operates across several regulated markets globally, including the U.S., and is ready to support the development of a federal framework for safe, sustainable, and equitable industry growth.
Flora Growth Corp. (NASDAQ: FLGC) has appointed Dr. Manfred Ziegler as Managing Director to bolster its German business. Dr. Ziegler, a renowned figure in the pharmaceutical industry, brings decades of expertise, including his leadership as Managing Director of CC Pharma and his role in its sale to Tilray. His appointment is expected to accelerate Flora's ambition to become a leading cannabis company in Germany.
Dr. Ziegler's extensive experience includes transforming CC Pharma into one of Europe's leading pharmaceutical distributors. His strategic leadership and proven ability to drive growth in complex markets will be instrumental as Flora expands its operations in Germany and Europe's cannabis sector. In his new role, Dr. Ziegler will focus on international distribution strategies, regulatory compliance, and market expansion, with a key objective to spearhead the launch of Flora's parallel import business in Germany.
Flora Growth Corp. (NASDAQ: FLGC) welcomes Germany's new industrial hemp legislation, which liberalizes cultivation and creates new opportunities for the industry. The updated regulatory framework, introduced by Food and Agriculture Minister Cem Özdemir, removes the restrictive 'abuse clause' and streamlines the path for producers. Industrial hemp, containing less than 0.3% THC, has versatile applications from textiles to wellness products.
Flora, with its established presence in the hemp cannabinoid space, is well-positioned to enter the German market. The company plans to leverage its expertise in cannabinoid extraction and product development, offering a range of high-quality, low-THC hemp products under its JustCBD and Vessel brands. CEO Clifford Starke expressed excitement about the potential in the European hemp market and Flora's commitment to expanding its international footprint.
Flora Growth Corp. (NASDAQ: FLGC) has partnered with Flowzz.com to establish a dedicated e-commerce store on the Flowzz Webshop, one of Germany's popular online cannabis marketplaces. This collaboration will integrate Flora's product line, including cannabis strains, flowers, and Vessel products, into the Flowzz platform. Flora will have exclusivity for accessories, cannabis seeds, cuttings, and seedlings.
Flowzz will manage the creation, maintenance, and marketing of the Flora Flowzz page, while Flora handles order fulfillment. This partnership aims to expand Flora's reach in the German market, which recently legalized recreational cannabis on April 1, 2024. With an estimated 4.5 million cannabis users in Germany as of February 2024, this collaboration positions Flora to capitalize on the growing European cannabis market.
Flora Growth Corp. (NASDAQ: FLGC) has announced the addition of Love Hemp's product range to its e-commerce platforms. This partnership expands Flora's product offering by introducing Love Hemp's functional products, oil sprays, chocolate balls, and 10-pack gummies to its online customers. The Love Hemp product line will complement Flora's existing portfolio without competing with JustCBD's current offerings.
Love Hemp is known for its innovative formulations and dedication to high-quality wellness products. Key products to be featured include a functional range designed for specific wellness benefits, convenient CBD oil sprays, CBD-infused chocolate balls, and 10-pack gummies. Clifford Starke, Chairman and CEO of Flora Growth, expressed enthusiasm about introducing Love Hemp's diverse product range to their growing customer base, stating that it further solidifies their commitment to providing top-tier, forward products that meet evolving consumer needs.
Flora Growth Corp. (NASDAQ: FLGC) has announced the appointment of Captain Hooter, a renowned cannabis connoisseur, as a special advisor. With over 30 years of experience, Captain Hooter will contribute to Flora's product development, brand positioning, and market expansion strategies. His expertise spans cultivation, consumption, and global cannabis markets.
Captain Hooter, founder of www.captainhooter.com, has studied cannabis across multiple countries and authored "Captain Hooter's Connoisseur's Guide to Amsterdam Coffee Shops." Flora plans to leverage his expertise to maintain high quality standards and potentially launch Captain Hooter-branded products in the future.
The collaboration aims to enhance Flora's competitive edge and deliver superior cannabis products worldwide. Captain Hooter's experience in addressing industry challenges, such as consistent product quality across markets, is expected to be valuable for Flora's growth objectives.
Flora Growth Corp. (NASDAQ: FLGC) has signed an exclusive distribution agreement with Nordic Tower AB for Vessel Brand products in Sweden and the Nordic region. Nordic Tower will become the exclusive distributor of Flora's Vessel Brand, known for high-quality vaping hardware, in Sweden, Norway, Denmark, Finland, and Iceland.
This partnership is part of Flora's European market expansion strategy, aiming to meet the growing demand for cannabis accessories. The collaboration will leverage Nordic Tower's market knowledge and online presence to ensure a strong entry for Vessel hardware in these countries.
The rollout of Vessel products is expected to begin in the fourth quarter of 2024, starting with Sweden and expanding to other Nordic countries. Nordic Tower will lead marketing and distribution efforts to gain visibility and traction for Vessel products in these markets.
Flora Growth Corp. (NASDAQ: FLGC) has expressed strong support for the Cannabinoid Safety and Regulations Act introduced by U.S. Senator Ron Wyden. This landmark legislation aims to establish a comprehensive framework for the safe production, labeling, and marketing of cannabinoid products to adults, with strict measures to prevent access by children.
The bill has gained backing from key industry organizations, including the U.S. Hemp Roundtable and the National Cannabis Industry Association. Flora's CEO, Clifford Starke, emphasized that the act represents a important step forward for the cannabis and hemp industries, creating a robust legal pathway for companies to deliver safe, high-quality cannabinoid products while ensuring rigorous testing, proper labeling, and age restrictions.
The proposed legislation addresses the growing demand for hemp-derived cannabinoid products like CBD and Delta-8 THC, establishing requirements for testing, labeling, and responsible marketing. Flora believes this bill will foster a more secure environment for businesses and consumers by providing clear regulations for the production and distribution of cannabinoid products.
Flora Growth Corp. (NASDAQ: FLGC) participated in the U.S. Hemp Roundtable's advocacy meetings in Washington, D.C., aimed at advancing legislation to support the hemp industry. Clifford Starke, Flora's Chairman and CEO, represented the company in discussions with lawmakers and congressional staffers. The meetings focused on advocating for clearer federal regulations, improved market access, and stronger protections for hemp-derived products.
Key topics included the need for clearer federal oversight of hemp-derived cannabinoids and ensuring the future of the U.S. hemp industry amid evolving policies. Mr. Starke expressed optimism about the outcomes, emphasizing Flora's commitment to being at the forefront of shaping the industry's regulatory landscape. The U.S. Hemp Roundtable, of which Mr. Starke is the Chairman, aims to promote sensible, science-based hemp regulations and create a clear path forward for the industry's growth.